Cell & Gene Therapy

Caribou antlers sitting on ground with mountains in background
Biotech

Caribou cuts 32% of staff, further purges cell therapy pipeline

The cuts are Caribou's second in less than a year, following another layoff round and the shuttering of an NK cell therapy program in July 2024.
Darren Incorvaia Apr 24, 2025 9:55pm
Terminated contract

NIH nixes financing for Pluri's radiation exposure cell therapy

Apr 18, 2025 9:10am
roadmap hurdles

Verve posts clean PCSK9 editor profile, teeing up Lilly decision

Apr 14, 2025 7:00am
Biotech year in review - The Top Line

Q1 biopharma layoff trends, plus expectations for Q2

Apr 11, 2025 9:25am
Puja Sapra AstraZeneca

ADCs to cell therapy: How AZ aims to 'redefine' oncology

Apr 9, 2025 11:44am
heart monitor

Lexeo locks in pivotal trial plan as gene therapy data accrue

Apr 7, 2025 9:37am
More News

Lilly saves gene therapy biotech with $18M upfront deal

Apr 3, 2025 6:00pm

Cell therapy biotech bags $102M to fund phase 3 epilepsy plans

Apr 3, 2025 1:22pm

Gene therapy biotech secures $150M for eye disease candidates

Apr 2, 2025 7:30am

Patient suffers side effect in Cabaletta CAR-T trial

Apr 2, 2025 6:55am